Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Nanocurcumin Versus Placebo for Patients Undergoing Radiotherapy for Prostate Cancer

NCT02724618 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.

NCT NCT02724618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02724618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Nanocurcumin Versus Placebo for Patients Undergoing Radiotherapy for Prostate Cancer
Lead sponsor
Shahid Beheshti University of Medical Sciences
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2016
Completion date
April 30, 2022
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer